FINAL EXAMINATION — 2026/2027
75 Questions | Multiple Choice | Questions, Answers, and Rationales
Total Questions: 75 | Passing Score: 75–80% | Testing Time: 120–150 minutes | Single best answer for each
question
1. A 68-year-old critically ill patient with septic shock has a serum albumin of 1.8 g/dL. The
AGACNP understands that hypoalbuminemia most significantly affects which
pharmacokinetic parameter?
A. Absorption of oral medications
B. Volume of distribution of highly protein-bound drugs
C. Hepatic first-pass metabolism
D. Renal tubular secretion of weak acids
Answer: B. Volume of distribution of highly protein-bound drugs
Rationale: Hypoalbuminemia reduces protein binding, increasing the free (active) fraction of highly
protein-bound drugs (e.g., phenytoin, warfarin). This increases the volume of distribution of the free drug
and may lead to toxicity at standard doses. Critical illness commonly causes hypoalbuminemia due to
capillary leak, hepatic dysfunction, and inflammation-mediated decreased synthesis.
2. A patient in the ICU on a continuous norepinephrine infusion develops refractory
hypotension requiring escalating doses. The AGACNP recognizes this phenomenon as
tachyphylaxis, which is best described as:
A. An immunoglobulin E–mediated allergic reaction to the medication
B. A rapidly decreasing response to a drug following repeated administration
C. An increased drug effect due to enzyme induction over time
D. A genetically determined variant in drug receptor sensitivity
Answer: B. A rapidly decreasing response to a drug following repeated administration
Rationale: Tachyphylaxis is a rapid decrease in response to a drug after repeated doses over a short
period. With catecholamines like norepinephrine, receptor downregulation (desensitization) occurs due to
prolonged receptor stimulation. This is pharmacodynamic tolerance, requiring dose escalation to maintain
hemodynamic effect.
3. A 55-year-old with acute respiratory distress syndrome (ARDS) is prescribed a hydrophilic
drug with a narrow therapeutic index. Which parameter is most important for dose
adjustment in this patient?
A. Volume of distribution
1
, B. Total body weight
C. Creatinine clearance
D. Serum protein binding
Answer: C. Creatinine clearance
Rationale: Hydrophilic drugs distribute primarily into total body water and are typically eliminated
renally. In critical illness, augmented renal clearance (ARC) is common in young, resuscitated patients and
can lead to subtherapeutic drug levels. Measured creatinine clearance is essential for dosing hydrophilic
drugs like vancomycin, aminoglycosides, and beta-lactams.
4. During the distributive phase of severe sepsis, capillary leak syndrome leads to which of
the following pharmacokinetic changes for lipophilic medications?
A. Decreased volume of distribution with higher peak serum concentrations
B. Increased volume of distribution with lower serum drug concentrations
C. Enhanced hepatic extraction ratio and increased clearance
D. Reduced renal clearance due to renal vasoconstriction
Answer: B. Increased volume of distribution with lower serum drug concentrations
Rationale: Capillary leak in sepsis increases endothelial permeability, allowing lipophilic drugs to
distribute more widely into extracellular and intracellular fluid. This increases the volume of distribution,
leading to lower initial serum concentrations. Loading doses may be needed to achieve therapeutic targets
for lipophilic drugs such as propofol, midazolam, and fentanyl.
5. A 72-year-old ICU patient with hepatic cirrhosis requires sedation. Which pharmacokinetic
alteration is most expected in this patient?
A. Increased first-pass metabolism leading to reduced bioavailability of oral drugs
B. Decreased plasma protein binding due to hypoalbuminemia and ascites
C. Enhanced renal elimination of phase II conjugated metabolites
D. Increased hepatic blood flow increasing drug clearance
Answer: B. Decreased plasma protein binding due to hypoalbuminemia and ascites
Rationale: Cirrhosis causes multiple pharmacokinetic changes: decreased albumin production reduces
protein binding; portosystemic shunting decreases first-pass metabolism; decreased CYP450 activity
reduces oxidative metabolism; and ascites increases the volume of distribution. These changes necessitate
careful dose reduction and therapeutic drug monitoring.
6. The AGACNP is managing a patient on a continuous infusion of fentanyl for analgesia.
Which pharmacodynamic principle explains why the context-sensitive half-time of fentanyl is
prolonged after 48 hours of infusion?
A. Autoinduction of hepatic CYP3A4 enzymes
B. Accumulation in peripheral compartments with slow redistribution
2
, C. Saturation of renal tubular secretion mechanisms
D. pH-dependent ion trapping in acidic body compartments
Answer: B. Accumulation in peripheral compartments with slow redistribution
Rationale: Fentanyl is highly lipophilic and accumulates in peripheral tissue compartments (fat, muscle)
during prolonged infusion. When the infusion is stopped, drug slowly redistributes from peripheral
compartments back to the central compartment, prolonging the context-sensitive half-time. This is why
awakening from prolonged fentanyl infusions takes significantly longer than from shorter infusions.
7. A patient with severe traumatic brain injury (TBI) is being initiated on levetiracetam for
seizure prophylaxis. Which pharmacokinetic consideration is most relevant?
A. Levetiracetam undergoes significant hepatic first-pass metabolism
B. Levetiracetam is highly protein-bound requiring albumin-adjusted dosing
C. Levetiracetam is primarily renally eliminated and requires dose adjustment with renal impairment
D. Levetiracetam has a narrow therapeutic index requiring serum level monitoring
Answer: C. Levetiracetam is primarily renally eliminated and requires dose adjustment with
renal impairment
Rationale: Levetiracetam is primarily eliminated renally (66% unchanged) and is not metabolized by the
CYP450 system. It has minimal protein binding (<10%), no significant drug interactions, and a wide
therapeutic index. Dose adjustment is required for creatinine clearance <80 mL/min, making it an ideal
antiepileptic in critical illness.
8. A septic patient receiving piperacillin-tazobactam via intermittent bolus dosing has a MIC
of 8 mcg/mL for the causative organism. The AGACNP understands that which dosing
strategy best optimizes pharmacodynamic target attainment for beta-lactams?
A. Once-daily high-dose administration to maximize Cmax/MIC
B. Extended or continuous infusion to maximize time above MIC (T>MIC)
C. Loading dose followed by decreased maintenance dosing
D. Twice-daily dosing with therapeutic drug monitoring of trough levels
Answer: B. Extended or continuous infusion to maximize time above MIC (T>MIC)
Rationale: Beta-lactams exhibit time-dependent killing, meaning their bactericidal activity correlates with
the duration the free drug concentration remains above the MIC (fT>MIC). Extended or continuous
infusion strategies optimize this parameter by maintaining steady concentrations above the MIC, which is
particularly important for organisms with elevated MICs, critically ill patients with augmented clearance,
and immunocompromised hosts.
9. A 62-year-old male with acute decompensated heart failure (HFrEF, EF 25%) presents with
dyspnea, JVD, and bilateral crackles. Which intravenous diuretic is the initial treatment of
choice according to current guideline-directed medical therapy?
3